Every year at the end of May, the International Day Against Multiple Sclerosis is marked all over the world. The reasons why this rare disease develops are still unknown. All people, even the young ones aged 18 to 34, are at risk. Although subsidies and access to innovative drugs for Ukrainians diagnosed with multiple sclerosis (MS) are increasing every year, official statistics on the diagnosis and treatment of the disease are disappointing. According to the latest independent study (IFAK Institute GmbH & Co, 2018) in Ukraine, 57 people per 100 thousand are diagnosed with MS (while in Hungary this number is 176, in the Czech Republic — 140, and in Poland — 120).